Elmwood Wealth Management’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-30,023
Closed -$218K 116
2023
Q1
$218K Buy
30,023
+16,025
+114% +$142K 0.1% 115
2022
Q4
$124K Sell
13,998
-10,127
-42% -$111K 0.06% 117
2022
Q3
$295K Sell
24,125
-16,025
-40% -$250K 0.15% 99
2022
Q2
$475K Buy
40,150
+127
+0.3% +$1.7K 0.27% 87
2022
Q1
$761K Hold
40,023
0.39% 78
2021
Q4
$1.06M Buy
+40,023
New +$1.38M 0.51% 66
2021
Q2
$2.27M Hold
40,023
1.19% 25
2021
Q1
$1.68M Buy
+40,023
New +$2.28M 1.03% 33
2020
Q3
$1.18M Hold
40,023
0.96% 33
2020
Q2
$1.18M Sell
40,023
-76,854
-66% -$2.01M 0.96% 33
2020
Q1
$3.87M Buy
116,877
+76,854
+192% +$1.94M 3.71% 2
2019
Q4
$1.19M Sell
40,023
-3,862
-9% -$96.5K 1.03% 35
2019
Q3
$998K Sell
43,885
-13,686
-24% -$339K 1.01% 40
2019
Q2
$1.42M Sell
57,571
-13,686
-19% -$327K 1.26% 24
2019
Q1
$1.74M Sell
71,257
-9,124
-11% -$207K 1.61% 12
2018
Q4
$1.83M Sell
80,381
-13,686
-15% -$372K 1.77% 11
2018
Q3
$2.99M Sell
94,067
-9,124
-9% -$295K 2.48% 6
2018
Q2
$3.7M Sell
103,191
-13,686
-12% -$485K 3.36% 2
2018
Q1
$3.87M Buy
+116,877
New +$4.16M 3.71% 2

Other funds holding EDIT

Elmwood Wealth Management's EDIT Position: Q2 2023 in Review

Elmwood Wealth Management sold out of Editas Medicine (EDIT) in Q2 2023, closing a stake of 30,023 shares — an estimated $218K sold.

Elmwood Wealth Management first reported a position in EDIT in Q1 2018 and held it in 19 quarters. The position peaked at $3.87M in Q1 2020. 238 funds tracked by Wall St. Rank hold EDIT as of Q2 2023.

  • Elmwood Wealth Management reported no remaining Editas Medicine position as of Q2 2023 after selling out during the quarter.
  • Elmwood Wealth Management sold 30,023 Editas Medicine shares in Q2 2023, an estimated $218K.
  • Elmwood Wealth Management first reported a position in Editas Medicine in Q1 2018 and held it in 19 quarters.
  • Elmwood Wealth Management's Editas Medicine position peaked at $3.87M in Q1 2020.
  • 238 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2023.

Based on Elmwood Wealth Management's 13F filing for Q2 2023, filed 10 Aug 2023.